Related Experiment Video
Updated: May 24, 2026
12:42
Photoactivated Localization Microscopy with Bimolecular Fluorescence Complementation (BiFC-PALM)
Published on: December 22, 2015
Polymeric human Fc-fusion proteins with modified effector functions
David N A Mekhaiel1, Daniel M Czajkowsky, Jan Terje Andersen
1Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Scientific Reports
|February 23, 2012
Summary
Researchers developed a method to create stable polymeric Fc-fusion proteins, reducing immunogenicity and offering potential for new therapies like intravenous immunoglobulin (IVIG). This platform enables exploration of Fc-fusion immune-complexes for disease treatment and vaccination.
Area of Science:
- Biotechnology
- Immunology
- Materials Science
Background:
- Fc-fusion bio-therapeutics are successful in treating diseases.
- Development of novel Fc-fusion products is ongoing for therapeutic and vaccination purposes.
- Modulating Fc-fusion function is key to enhancing their therapeutic potential.
Purpose of the Study:
- To describe a method for converting Fc-fusions into well-defined stable polymers.
- To investigate the structural and functional properties of these polymeric Fc-fusions.
- To assess the potential of this platform for therapeutic and vaccination applications.
Main Methods:
- Utilized atomic force microscopy (AFM) to characterize the structure of polymeric Fc-fusions.
- Compared the immunogenicity of polymeric Fc-fusions with their monomeric and dimeric counterparts.
- Assessed the binding affinity of polymeric IgG1-Fc molecules to Fc-receptors (FcγRs).
Main Results:
- A method was established to create stable, cylindrical hexameric Fc-fusion polymers.
- Polymeric Fc-fusions exhibited significantly reduced immunogenicity compared to lower-order forms.
- Polymeric IgG1-Fc molecules showed selective binding to FcγRs with increased affinity due to valency.
Conclusions:
- Developed an effective IgG Fc-fusion based polymeric platform.
- Polymeric Fc-fusions demonstrate reduced immunogenicity and potential for therapeutic applications.
- This platform facilitates exploration of Fc-fusion immune-complexes for disease treatment and vaccination, including potential IVIG replacements.
Related Concept Videos
01:57Protein Complexes with Interchangeable Parts
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
01:24Tagging and Fusion Proteins
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.